Literature DB >> 3067950

Long-term correction of hyperglycemia and progression of retinopathy in insulin dependent diabetes. A five-year randomized prospective study.

A Verrillo1, A de Teresa, C Martino, L Verrillo, G di Chiara.   

Abstract

Thirty-eight patients with insulin dependent diabetes mellitus who had background retinopathy and no residual endogenous insulin secretion as assessed by plasma C-peptide determinations, were randomized to either conventional insulin treatment or to more intensive glucose control using ultralente insulin as basal cover and soluble insulin at mealtimes and were followed for five years. Plasma glucose profile and glycosylated hemoglobin were determined every eight weeks. Eye examinations were performed at the start of the study and after one, three and five years. Age, duration of diabetes, insulin dosage, glycemic control were comparable in the two groups. The mean plasma glucose profile was similar at entry in both groups and did not change in the conventionally-treated group. Mean plasma glucose profile 11.2 +/- 1 mmol/l with glycosylated hemoglobin level 10.7 +/- 0.3% fell to 7.9 +/- 0.4 mmol/l and 8.7 +/- 0.5% respectively during intensive treatment. Retinal morphology deteriorated during the follow-up with no significant differences between patients under unchanged conventional treatment and intensive insulin regimen. Proliferative retinopathy developed in six patients--three of these were under intensive insulin treatment. These data suggest that substantial long-term improvement of glycemic control does not affect progression of background retinopathy even when it is mild. The evolution of established retinopathy in insulin dependent diabetic patients is not only a function of poor glycemic control; other factors, either intrinsic or environmental, must also be important.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3067950

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  3 in total

1.  Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.

Authors:  F S Nielsen; L N Jørgensen; M Ipsen; A I Voldsgaard; H H Parving
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

Review 2.  Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.

Authors:  Pernille Kähler; Berit Grevstad; Thomas Almdal; Christian Gluud; Jørn Wetterslev; Søren Søgaard Lund; Allan Vaag; Bianca Hemmingsen
Journal:  BMJ Open       Date:  2014-08-19       Impact factor: 2.692

Review 3.  Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Authors:  Birgit Fullerton; Klaus Jeitler; Mirjam Seitz; Karl Horvath; Andrea Berghold; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2014-02-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.